Close X
Tuesday, November 26, 2024
ADVT 
International

Flood situation in Pak highly likely to boost disease spread: WHO

Darpan News Desk IANS, 01 Sep, 2022 11:13 AM
  • Flood situation in Pak highly likely to boost disease spread: WHO

Islamabad, Sep 1 (IANS) The catastrophic flood situation in Pakistan will highly likely increase the spread of disease, says the World Health Organization (WHO), as the country continues its relentless battle against the deadly deluges.

In its latest situation report on flooding in Pakistan, the WHO pointed out that the heavy monsoon rain which started in mid-June are continuing in many parts of the country and have affected 116 districts (75 per cent) out of the total 160, Geo News reported.

The most affected province is Sindh, followed by Balochistan.

As of August 25, more than 33 million people have been affected and over 6.4 million people are in dire need of humanitarian aid, including 421,000 refugees, the WHO report highlighted.

More than 1,100 lives have been lost and almost 15,000 people injured.

The WHO report focused on what it called the "severe" impact on health facilities, stating that as of August 28, 888 health facilities have been damaged in the country of which 180 of them are completely damaged.

Photo courtesy of IANS. 

"Access to health facilities, health care workers, and essential medicines and medical supplies remain the main health challenges for now," Geo News quoted the WHO report as saying.

Pakistan's health system is already battling multiple concurrent health threats, including Covid-19, and outbreaks of cholera, typhoid, measles, leishmaniasis and HIV, the WHO said, adding that even before the current floods, there was a significant disparity in access to health services between rural and urban areas.

Meanwhile, health experts have sounded the alarm regarding the outbreak of disease in flood-affected areas, estimating around five million people to fall sick in the next four to 12 weeks.

MORE International ARTICLES

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot

WHO grants emergency authorization for J&J COVID vaccine

WHO grants emergency authorization for J&J COVID vaccine
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

WHO grants emergency authorization for J&J COVID vaccine